Browse by category

The proportion of adolescents living with overweight or obesity in England has increased by 50% from 2008-2010 (22%) to 2021-2023 (33%),...

Weight loss programmes targeting a particular percentage of weight loss are often failing, and that other factors should be considered...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...

Women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and...

First generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss. Indeed,...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may help to reduce the risk of heart attacks, strokes, and other major adverse...

The 13th Congress of the IFSO European Chapter (EC), taking place from May 15–17, 2025, in the enchanting city of Venice, Italy, will...

Spend an engaging hour with Researcher 2 Researcher   and Bariatric News   as we explore a range of topics in Bariatric and Metabolic...